Sarah A. Weiss

Rutgers, The State University of New Jersey — United States

Medicine · Health Sciences

28h-index3.6kcitations175works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(102), Immunotherapy and Immune Responses(64), CAR-T cell therapy research(48), Cutaneous Melanoma Detection and Management(14), Immune Cell Function and Interaction(14)

Publications175 total

Ex vivo expansion of melanoma tumor infiltrating lymphocytes leads to a dominant exhausted T cell population with lack of memory markers
Cancer Immunology Research·2026
Supplementary Figures from Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance
2025Open Access
Supplementary Table S2 from Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance
2025Open Access
Supplementary Table S1 from Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance
2025Open Access
Supplementary Table S3 from Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance
2025Open Access
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma
Nature Communications·2025· 6 citedOpen Access
Case Report: Recurrent supraglottitis in a patient with metastatic melanoma treated with ipilimumab and nivolumab
Frontiers in Oncology·2025· 2 citedOpen Access
A randomized phase 2 peri-operative (neoadjuvant plus adjuvant) study of fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) versus anti–PD-1 alone in patients with resectable stage III and IV melanoma.
Journal of Clinical Oncology·2025· 2 cited
Abstract LB066: Cytokine and chemokine screening reveals altered NK-DC-T cell crosstalk in the aged tumor microenvironment
Cancer Research·2025
Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases
Journal of Clinical Oncology·2025· 8 cited
Metastatic Merkel Cell Carcinoma Incidentally Detected on PSMA PET/CT in a Patient With Metastatic Prostate Cancer
Case Reports in Radiology·2025Open Access
Real-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinoma
Surgical Oncology Insight·2024· 1 citedOpen Access
Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology
Urology·2024· 5 cited
Supplementary Table S1 from Combinatorial immunotherapy with agonistic CD40 activates dendritic cells to express IL12 and overcomes PD-1 resistance
2024Open Access
Supplementary Figure 1 from A Phase II Trial of the CD40 Agonist Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Disease Progression on Anti-PD-1
2024Open Access
Data from Combinatorial immunotherapy with agonistic CD40 activates dendritic cells to express IL12 and overcomes PD-1 resistance
2024Open Access
Data from A Phase II Trial of the CD40 Agonist Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Disease Progression on Anti-PD-1
2024Open Access
Supplementary Table S2 from Combinatorial immunotherapy with agonistic CD40 activates dendritic cells to express IL12 and overcomes PD-1 resistance
2024Open Access
Supplementary Data 1 from A Phase II Trial of the CD40 Agonist Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Disease Progression on Anti-PD-1
2024Open Access
Supplementary Figures from Combinatorial immunotherapy with agonistic CD40 activates dendritic cells to express IL12 and overcomes PD-1 resistance
2024Open Access
page 1 of 9Next →

Frequent Co-authors

Harriet M. Kluger(21), Mario Sznol(10), Lucia B. Jilaveanu(8), Iman Osman(7), Thuy Tran(6), Kelly Olino(6), Amit Mahajan(5), Christopher R. Zito(5), Douglas B. Johnson(4), Veronica Chiang(4), Wei Wei(4), William Damsky(4), Judy Zhong(4), Adebowale Adeniran(4), Ana Luisa Perdigoto(3), Farbod Darvishian(3), Justine V. Cohen(3), Gail D. Anderson(3), Yuval Kluger(3), Dijana Djureinovic(3)